Trials / Completed
CompletedNCT06567405
Derma Pen as Treatment of Gingivitis Induced by Orthodontics
Impact of Derma Pen in the Treatment of Gingivitis Induced by Orthodontic Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Safa Basiouny Alawy · Academic / Other
- Sex
- All
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
Although orthodontic therapy frequently improves tooth alignment and appearance, its problems with oral hygiene can make patients highly susceptible to gingivitis. After orthodontic treatment, gingivitis is a typical problem. New treatments that promote healing and decrease inflammation are needed. Ascorbic acid and Derma Pen used together have recently surfaced as a potentially effective therapy option for patients who seeking for periodontal therapy during and after orthodontic treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | mechanical periodontal treatment | Patients will undergo subgingival scaling employing a Piezoelectric ultrasonic scaler to eliminate local factors. |
| DEVICE | Derma pen with topical ascorbic Acid | local anesthesia of 2% lignocaine will be administered by infiltration technique in the anterior maxillary region. Microneedling of the mucosa will be performed using dermapen needles, employing an intermittent back-and-forth motion in the anterior maxillary and mandibular region for 30-40 seconds, reaching a depth of 1.5 mm. This will involve the creation of microholes in the gingival tissue using derma pen to enhance the concentration and penetration of the ascorbic Acid through the gingival tissues. |
Timeline
- Start date
- 2024-05-30
- Primary completion
- 2024-12-01
- Completion
- 2025-02-07
- First posted
- 2024-08-22
- Last updated
- 2025-05-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06567405. Inclusion in this directory is not an endorsement.